The Impact of Systematic Prostate Biopsy on Prostate Cancer Incidence in Men With Symptomatic Benign Prostatic Hyperplasia Undergoing Transurethral Resection of the Prostate

Abstract

Clinically relevant prostate cancers may be detected in a significant proportion (more than 15%) of men undergoing transurethral resection of the prostate for symptomatic BPH despite prior screening with serum PSA, digital rectal examination and 1 or more systematic needle biopsies of the prostate.